ReviewJournal of blood medicine2021

Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence.

Yesim Dargaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.